Latest Global Growth News

TruScreen Ordinary Shares Group Limited has announced a combined share purchase plan and placement to raise approximately NZD 1.78 million, aiming to accelerate its international expansion and cervical cancer screening initiatives.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.

RooLife Group Ltd (ASX:RLG) has secured its first $475,000 solar product order from India, marking a significant step in its global renewable energy expansion. This milestone underscores RLG’s unique model blending Chinese manufacturing with international marketing and distribution.

Gentrack reported a solid 9.8% revenue increase to NZ$112 million in HY25, driven by recurring revenue growth and international expansion, while net profit after tax surged 34.7%. The company’s outlook remains optimistic as it targets FY25 revenue above NZ$230 million and deeper market penetration across Asia, Europe, and the Middle East.

Gentrack Group Ltd reported a robust 9.8% revenue increase and a 34.7% jump in net profit for the first half of FY25, driven by strong recurring revenues and strategic global expansion.

WCM Global Growth Limited has announced an increased fully franked dividend for Q3 FY2025, alongside a progressive dividend policy forecasting steady growth through FY2026. The company’s strong investment performance underpins this confident outlook.

ClearVue Technologies has inked a five-year exclusive manufacturing and distribution agreement with New Zealand’s Viridian Glass, marking its strategic entry into the New Zealand market with solar-integrated glazing solutions.

Acrux Limited has appointed John Warmbrunn as its new CEO and Managing Director, signaling a strategic push for international expansion and product development starting June 2025.

Merino & Co reported a transformative quarter marked by operational upgrades, new product launches, and the integration of cryptocurrency payments, ending with a robust cash position to fuel future growth.

Pureprofile Limited reported a robust 16% revenue increase in Q3 FY25, driven by strong international expansion and new AI-powered solutions, while reaffirming its FY25 financial guidance.

Pureprofile Limited has reported a robust Q3 FY25 with revenue up 16% and EBITDA up 16% year-on-year, driving a 20% increase in year-to-date revenue and a 35% jump in EBITDA. The company’s international expansion and new AI-driven solutions underpin its confident outlook for FY25.

Opyl Limited reports strong progress in AI-driven clinical trial optimisation with active commercial initiatives, strategic partnerships, and a planned capital raise to support growth amid tight cash reserves.